President Trump to Announce Nationwide Medicaid Drug Pricing Model
President Trump will announce that all 50 states are joining a Medicaid drug pricing model designed to lower the net price of selected drugs by aligning them with prices paid in certain other countries.
Mobile Pensacola, AL, September 18, 2026 —
President Trump is expected to announce that all 50 states will participate in a new Medicaid drug pricing model. This initiative is designed to reduce the net price of selected prescription drugs.
The proposed model aims to achieve lower drug costs by aligning the prices paid for certain medications with those paid in specific other countries. The announcement is anticipated to detail the framework of this nationwide drug pricing strategy for Medicaid programs.
Details regarding the specific selection criteria for drugs included in the model, the exact foreign countries used as benchmarks, and the projected timeline for implementation were not immediately available in the summary. The summary also did not specify the mechanism by which states will join or the expected impact on pharmaceutical manufacturers or patient access to medications. Further information is expected following the President’s announcement.
Story summarized from the original created by FATIMA HUSSEIN, Associated Press on www.wkrg.com, see more information here.
Media gallery
